The EpiPen was a perfect symbol of the current state of pharmaceutical companies and health care expenses: It was a life-saving drug that had been around for decades, often used by children, and with a price that kept rising. The controversy over the epinephrine injectors led to news stories, a Congressional hearing, a $465 million settlement for overcharging Medicaid, and investigations by the states of New York and West Virginia. [More]
federal investigations
FTC Opens Antitrust Investigation Of Mylan Over EpiPen’s Market Dominance
By 1.30.17 — Updated: 1.31.17
FTC Investigates Twitter For The Way It Deals With Third-Party App Makers
By 7.1.11
Twitter has found itself in the Federal Trade Commission’s cross hairs once again, this time over its treatment of companies that develop applications for the service. In March, Twitter settled with the FTC following an investigation of privacy violation allegations. [More]
